Aadi Bioscience, Inc. (AADI)

Aadi Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	53.78	62.89	39.02	148.99	4.46	38.56
Short-Term Investments	34.49	45.96	133.54	0	0	0
Cash & Cash Equivalents	88.27	108.85	172.56	148.99	4.46	38.56
Cash Growth	-41.61%	-36.92%	15.82%	3244.31%	-88.45%	-38.45%
Receivables	4.93	5.49	1.86	0	14.15	0
Inventory	5.94	6.43	1.86	0	0	0
Other Current Assets	3.43	3.83	3.75	2.28	0.08	1.01
Total Current Assets	102.57	124.59	180.03	151.27	18.69	39.57
Property, Plant & Equipment	6.76	5.97	2.03	0.61	0.14	0.33
Goodwill and Intangibles	0	0	0	3.81	0	0
Other Long-Term Assets	1.74	1.87	2.18	2.21	0	0.04
Total Long-Term Assets	8.5	7.84	4.21	6.64	0.14	0.37
Total Assets	111.07	132.42	184.24	157.91	18.83	39.94
Accounts Payable	3.1	5.9	9.28	12.2	16.71	3.23
Current Debt	0.43	0.43	0.39	0.13	9.15	0.1
Other Current Liabilities	16.36	20.06	9.17	2.95	4.2	0
Total Current Liabilities	19.88	26.4	18.84	15.27	30.06	3.33
Long-Term Debt	0.74	0.83	1.27	0.47	1.1	0.07
Other Long-Term Liabilities	0	0	5.76	5.76	0.1	0
Total Long-Term Liabilities	0.74	0.83	7.02	6.23	1.2	0.07
Total Liabilities	20.61	27.23	25.86	21.5	31.26	3.4
Total Debt	1.16	1.27	1.66	0.61	10.26	0.17
Debt Growth	-25.83%	-23.72%	174.55%	-94.10%	5933.19%	-
Retained Earnings	-287.25	-268.96	-203.2	-142.69	-32.6	-142.24
Comprehensive Income	-0.01	0.03	-0.12	0	0	0
Shareholders' Equity	90.46	105.2	158.38	136.41	-12.43	36.54
Net Cash / Debt	87.11	107.58	170.9	148.38	-5.8	38.39
Net Cash / Debt Growth	-41.78%	-37.05%	15.17%	-	-	-38.72%
Net Cash Per Share	3.23	4.00	7.59	16.63	-2.28	14.19
Working Capital	82.7	98.19	161.19	136	-11.37	36.24
Book Value Per Share	3.35	3.91	7.04	15.29	-4.89	13.50

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).